Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome

CONTEXT: Polycystic ovary syndrome (PCOS), a highly prevalent endocrine disorder characterized by hyperandrogenism, is the leading cause of anovulatory infertility. OBJECTIVE: This proof-of-concept study evaluated clinical efficacy and safety of the neurokinin 3 (NK3) receptor antagonist fezolinetan...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraser, Graeme L, Obermayer-Pietsch, Barbara, Laven, Joop, Griesinger, Georg, Pintiaux, Axelle, Timmerman, Dirk, Fauser, Bart C J M, Lademacher, Christopher, Combalbert, Jean, Hoveyda, Hamid R, Ramael, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372662/
https://www.ncbi.nlm.nih.gov/pubmed/34000049
http://dx.doi.org/10.1210/clinem/dgab320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372662/
https://www.ncbi.nlm.nih.gov/pubmed/34000049
http://dx.doi.org/10.1210/clinem/dgab320

Ejemplares similares